Mead Johnson Nutrition CO  

(Public, NYSE:MJN)   Watch this stock  
Find more results for MJN
71.90
+2.26 (3.25%)
Feb 5 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 69.14 - 72.38
52 week 65.53 - 105.45
Open 69.63
Vol / Avg. 4.79M/2.72M
Mkt cap 13.72B
P/E 21.30
Div/yield 0.41/2.29
EPS 3.37
Shares 186.40M
Beta 1.06
Inst. own 110%
May 4, 2016
Mead Johnson Nutrition Co Annual Shareholders Meeting Add to calendar
Apr 29, 2016
Mead Johnson Nutrition Co Annual Shareholders Meeting (Estimated) - 10:00AM EDT - Add to calendar
Apr 28, 2016
Q1 2016 Mead Johnson Nutrition Co Earnings Release (Tentative) - 9:30AM EDT - Add to calendar
Apr 28, 2016
Q1 2016 Mead Johnson Nutrition Co Earnings Call (Tentative) Add to calendar
Jan 28, 2016
Q4 2015 Mead Johnson Nutrition Co Earnings Release
Jan 28, 2016
Q4 2015 Mead Johnson Nutrition Co Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 13.55% 16.10%
Operating margin 20.25% 23.00%
EBITD margin - 25.43%
Return on average assets 13.51% 16.89%
Return on average equity - -
Employees 7,700 -
CDP Score - 92 B

Address

2701 Patriot Blvd Fl 4
GLENVIEW, IL 60026-8039
United States - Map
+1-847-8322420 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders. The Company operates through three segments: Asia, Latin America and North America/Europe. The Company's Enfa family of brands, including Enfamil infant formula, is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants, children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers, healthcare professionals and retailers in more than 50 countries in Asia, North America, Latin America and Europe.

Officers and directors

Peter Kasper Jakobsen President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Michel M.G. Cup Chief Financial Officer, Executive Vice President
Age: 45
Bio & Compensation  - Reuters
Charles M. Urbain Chief Operating Officer, Executive Vice President
Age: 61
Bio & Compensation  - Reuters
James E. Shiah Senior Vice President, Chief Accounting Officer, Corporate Controller
Age: 56
Bio & Compensation  - Reuters
Patrick M. Sheller Senior Vice President, General Counsel, Secretary
Age: 53
Bio & Compensation  - Reuters
James Jeffrey Jobe Senior Vice President - Technical Operations
Age: 55
Bio & Compensation  - Reuters
Dirk Hondmann Ph.D. Chief Scientific Officer
Age: 51
Bio & Compensation  - Reuters
James M. Cornelius Non-Executive Chairman of the Board
Age: 71
Bio & Compensation  - Reuters
Stephen W. Golsby Director
Age: 60
Bio & Compensation  - Reuters
Charles Elliott Sigal M.D., Ph.D. Director
Age: 63
Bio & Compensation  - Reuters